Experiences, challenges, and their mitigation during COVID convalescent plasma donation management: Data from a single center in India

Experiences, challenges, and their mitigation during COVID convalescent plasma donation management: Data from a single center in India

Background and Objectives: ICMR conducted a multicentric trial “PLACID” that allowed COVID convalescent plasma (CCP) as an experimental drug for the management of moderate COVID-19 disease and the authors' institute was one of the participating centers. The efficacy of CCP in COVID-19 is still...

Full description

Bibliographic Details
Main Authors: Geet Aggarwal, Aseem Kumar Tiwari, Swati Pabbi, Arghyadeep Marik, Ganesh Rawat, Jyoti Sharma, Nixon P Joseph, Vikash Vashisth, Govind Sharma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Global Journal of Transfusion Medicine
Subjects:
apheresis
covid convalescent plasma
covid-19
donor management
plasma therapy
Online Access:http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2022;volume=7;issue=1;spage=65;epage=70;aulast=Aggarwal

Internet

http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2022;volume=7;issue=1;spage=65;epage=70;aulast=Aggarwal

Similar Items